Peptide imaging agents
US8431111B2 · kind B2 · utility
19Cited by
0References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2008 |
| Grant date | Apr 30, 2013 |
| Priority date | — |
| Expiry date | Jun 10, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B5/4842
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to labelled cMet binding peptides suitable for optical imaging in vivo. The peptides are labelled with a benzopyrylium dye suitable for imaging in the red to near-infrared region. Also disclosed are pharmaceutical compositions and kits, as well as in vivo imaging methods, especially of use in the detection, staging, diagnosis, monitoring of disease progression or monitoring of treatment of colorectal cancer (CRC).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.